August 16, 2022
At least four drugs saw their authorized generics (AGs) approved on August 15 in a generic approval round towards December listing, including AstraZeneca’s proton pump inhibitor (PPI) Nexium (esomeprazole) and Otsuka Pharmaceutical’s diuretic agent Samsca (tolvaptan). Nexium was the centerpiece...read more